Summit Partners Public Asset Management, LLC Karuna Therapeutics, Inc. Transaction History

Summit Partners Public Asset Management, LLC

  • $2.79 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$161.01 - $317.85 $7.96 Million - $15.7 Million
-49,467 Reduced 50.8%
47,910 $15.2 Million
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $2.78 Million - $3.68 Million
16,896 Added 20.99%
97,377 $16.5 Million
Q2 2023

Aug 14, 2023
BUY
$176.32 - $240.22 $5 Million - $6.82 Million
28,381 Added 54.47%
80,481 $17.5 Million
Q1 2023

May 15, 2023
BUY
$161.33 - $204.36 $8.41 Million - $10.6 Million
52,100 New
52,100 $9.46 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email